Obesity and inflammatory biomarkers in women with polycystic ovary syndrome
- 1 September 2015
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 192, 66-71
Abstract
No abstract availableKeywords
Funding Information
- Taiwan National Science Council (NSC 102-2629-B-038-001)
- Taipei Medical University – Wan Fang Hospital (103-wf-eva-10)
This publication has 22 references indexed in Scilit:
- Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive ageFertility and Sterility, 2014
- Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: An experimental and clinical updateEndocrine Connections, 2013
- The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative reviewMetabolism, 2013
- Obesity and Metabolic Syndrome: An Inflammatory ConditionDigestive Diseases, 2012
- Antimüllerian hormone and polycystic ovary syndromeFertility and Sterility, 2011
- Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysisFertility and Sterility, 2011
- Cardiovascular risk in postmenopausal women with the polycystic ovary syndromeMaturitas, 2011
- Clinical Significance of Inflammatory Markers in Polycystic Ovary Syndrome: Their Relationship to Insulin Resistance and Body Mass IndexDisease Markers, 2009
- Indices of Low‐Grade Inflammation in Polycystic Ovary SyndromeAnnals of the New York Academy of Sciences, 2006
- Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parametersJournal of Endocrinological Investigation, 2004